secwatch.observer — SEC 8-K summary
======================================

Issuer:     USBC, Inc. (USBC)
CIK:        0001074828
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001654954-24-002728
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Know Labs’ RF glucose sensor achieves 11.1% MARD in first venous-blood study
----------------------------------------------------------------------------

- Overall MARD of 11.1±2.1% in test dataset; similar accuracy in normoglycemic (11.0%) and hyperglycemic (11.5%) ranges.
- First study using venous blood as reference in participants with prediabetes and Type 2 diabetes.
- Study involved 21 three-hour sessions with 75g OGTT; 520 paired values for training, 130 for test.
- Clinical trial completed (up to 100 participants, Sep 2023–Feb 2024); company plans large-scale external trials in 2024.
- Dr. Virend K. Somers of Mayo Clinic is co-investigator; results presented at ATTD conference in Florence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1074828/000165495424002728/0001654954-24-002728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1074828/000165495424002728/knwn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-002728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer